Novo Nordisk News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.12.17	MÄRKTE EUROPA/Alles schwach - Steinhoff wird zum Penny-Stock (Dow Jones)
06.12.17	Novo Nordisk-Aktie fester: Novo Nordisk erhält US-Zulassung für Diabetesmedikament (Dow Jones) Der dänische Pharmakonzern Novo Nordisk hat einen Zulassungserfolg in den USA verbucht.» mehr
06.12.17	NVO Gets FDA Nod, GALT Down But Not Out, BIOC Gets A Boost, CUR Excited (RTTNews)
04.12.17	TAPCO Announces New Location in White Bear Lake, Minnesota (PR Newswire)
30.11.17	Phase III STRIVE study data for erenumab (AMG334) in migraine prevention published in The New England Journal of Medicine(1) (PR Newswire)
29.11.17	Biotech Stocks Facing FDA Decision In December (RTTNews)
25.11.17	How the CFO of a $12 Billion Biotech Startup Eliminated the Frustrations of Lab Procurement through Procurify (PR Newswire)
24.11.17	IIROC Trading Resumption - NVO (PR Newswire)
24.11.17	IIROC Trading Resumption - NVO (PR Newswire)
24.11.17	IIROC Trading Halt - NVO (PR Newswire)
24.11.17	IIROC Trading Halt - NVO (PR Newswire)
21.11.17	Health Canada approves Victoza® as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. (PR Newswire)
21.11.17	Health Canada approves Victoza® as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. (PR Newswire)
21.11.17	Novo Nordisk To Present Updates On R&D And Commercial Strategy (RTTNews)
16.11.17	IIROC Trading Resumption - NVO (PR Newswire)
16.11.17	IIROC Trading Resumption - NVO (PR Newswire)
16.11.17	IIROC Trading Halt - NVO (PR Newswire)
16.11.17	IIROC Trading Halt - NVO (PR Newswire)
15.11.17	Diabetes Community Awakens Important Conversation about Hidden Problem: Hypoglycemia (PR Newswire)
15.11.17	Diabetes Community Awakens Important Conversation about Hidden Problem: Hypoglycemia (PR Newswire)
08.11.17	"Diabetes 360" Survey Shows Patients Want More Than Medicine, Need Emotional Support (PR Newswire)
08.11.17	Chubb Donates Damaged Yves Klein Sculpture to Artist's Archives (PR Newswire)
08.11.17	Canadians' perceptions of ill, wounded and injured veterans have shifted dramatically following Invictus Games; poll (PR Newswire)
07.11.17	TSO3 Reports Record Third Quarter 2017 Results (PR Newswire)
01.11.17	MÄRKTE EUROPA/DAX setzt Rekordserie fort (Dow Jones)
01.11.17	Novo Nordisk 9-Month Profit Rises, Lifts FY17 Forecast; Sees Growth In FY18 (RTTNews)
19.10.17	FDA Blesses 2nd CAR-T Cell Therapy, NVO One Step Away From Approval, AKTX Slumps (RTTNews)
19.10.17	NVO : Semaglutide Gets Positive Vote In Favour Of Approval From FDA Panel (RTTNews)
18.10.17	Novo Nordisk receives positive 16-0 vote from FDA Advisory Committee in favor of approval for semaglutide (PR Newswire)
17.10.17	Baylis Medical and Siemens Healthineers co-sponsor physician training for state-of-the art, minimally invasive heart procedure (PR Newswire)
11.10.17	Advance voting in federal by-elections begins Friday (PR Newswire)
09.10.17	Atlatsa Resources Corporation Announces Update on Delay in Filing of Unaudited Interim Financial Statements (PR Newswire)
09.10.17	New Drugs Approved In September (RTTNews)
08.10.17	New Flyer Industries Inc. Introduces NFI Parts™ Brand (PR Newswire)
05.10.17	IIROC Trade Resumption - HNL (PR Newswire)
03.10.17	The Canadian Medical Hall of Fame honours excellence in health in Canada: announcing the 2018 inductees (PR Newswire)
03.10.17	Striking Blood Sugar Balance is Critical for Canadians Living with Diabetes (PR Newswire)
03.10.17	Striking Blood Sugar Balance is Critical for Canadians Living with Diabetes (PR Newswire)
02.10.17	ZGNX Leaps On Trial Data, NVO Gets It Right The 2nd Time, MNKD On Watch (RTTNews)
29.09.17	Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin (PR Newswire)
15.09.17	Wells Fargo Commercial Mortgage Trust 2016-NXS6 -- Moody's Affirms Seven Classes of WFCM 2016-NXS6 (Moodys)
12.09.17	MSC Industrial Supply Co. to Webcast Review of 2017 Fiscal Fourth Quarter and Full Year Results (PR Newswire)
06.09.17	MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet (RTTNews)
05.09.17	Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices (PR Newswire)
28.08.17	Novo Nordisk : Canada Oks Tresiba, New Basal Insulin For Type 1 And 2 Diabetes (RTTNews)
27.08.17	Novo Nordisk Diabetes Drug Victoza Approved In US To Reduce Cardiovascular Risk (RTTNews)
25.08.17	Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to reduce the risk of three major adverse cardiovascular events (PR Newswire)
16.08.17	Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma (PR Newswire)
09.08.17	MÄRKTE EUROPA/Säbelrasseln rund um Nordkorea belastet (Dow Jones)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	237.10	1.80 %	K V
ABB	42.20	1.44 %	K V
Nestle	87.98	1.36 %	K V
Swiss Re	141.80	1.18 %	K V
CieFinRichemont	136.90	1.00 %	K V
Sika	195.55	-0.23 %	K V
Lonza Grp	539.20	-0.44 %	K V
Alcon	75.38	-0.48 %	K V
Holcim	87.62	-0.88 %	K V
Geberit	551.20	-1.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Novo Nordisk Aktie VALOR 461641 / ISIN US6701002056

Nachrichten zu Novo Nordisk (spons. ADRs)

Aktien Top/Flop

Novo Nordisk Peer Group Nachrichten

Meistgelesene Nachrichten